231 related articles for article (PubMed ID: 18541399)
1. MR imaging of tumor angiogenesis using sterically stabilized Gd-DTPA liposomes targeted to CD105.
Zhang D; Feng XY; Henning TD; Wen L; Lu WY; Pan H; Wu X; Zou LG
Eur J Radiol; 2009 Apr; 70(1):180-9. PubMed ID: 18541399
[TBL] [Abstract][Full Text] [Related]
2. Molecular imaging of angiogenesis to delineate the tumor margins in glioma rat model with endoglin-targeted paramagnetic liposomes using 3T MRI.
Qiu LH; Zhang JW; Li SP; Xie C; Yao ZW; Feng XY
J Magn Reson Imaging; 2015 Apr; 41(4):1056-64. PubMed ID: 24677456
[TBL] [Abstract][Full Text] [Related]
3. [Folate-poly-L-lysine-Gd-DTPA as MR contrast agent for tumor imaging via folate receptor-targeted delivery].
Yuan Z; Liu SY; Xiao XS; Zhong GR; Jiang QJ
Zhonghua Yi Xue Za Zhi; 2007 Mar; 87(10):673-8. PubMed ID: 17553304
[TBL] [Abstract][Full Text] [Related]
4. Noninvasive assessment of the functional neovasculature in 9L-glioma growing in rat brain by dynamic 1H magnetic resonance imaging of gadolinium uptake.
van der Sanden BP; Rozijn TH; Rijken PF; Peters HP; Heerschap A; van der Kogel AJ; Bovée WM
J Cereb Blood Flow Metab; 2000 May; 20(5):861-70. PubMed ID: 10826537
[TBL] [Abstract][Full Text] [Related]
5. Intra-individual comparison of different gadolinium-based contrast agents in the quantitative evaluation of C6 glioma with dynamic contrast-enhanced magnetic resonance imaging.
Li Y; Liu G; Lou X; Chen Z; Ma L
Sci China Life Sci; 2017 Jan; 60(1):11-15. PubMed ID: 28078511
[TBL] [Abstract][Full Text] [Related]
6. Liposomal Gd-DTPA: effect of encapsulation on enhancement of hepatoma model by MRI.
Unger EC; MacDougall P; Cullis P; Tilcock C
Magn Reson Imaging; 1989; 7(4):417-23. PubMed ID: 2811620
[TBL] [Abstract][Full Text] [Related]
7. Thiol-PEG-carboxyl-stabilized Fe₂O ₃/Au nanoparticles targeted to CD105: synthesis, characterization and application in MR imaging of tumor angiogenesis.
Zhang S; Gong M; Zhang D; Yang H; Gao F; Zou L
Eur J Radiol; 2014 Jul; 83(7):1190-1198. PubMed ID: 24832501
[TBL] [Abstract][Full Text] [Related]
8. Cellular uptake and in vitro antitumor efficacy of composite liposomes for neutron capture therapy.
Peters T; Grunewald C; Blaickner M; Ziegner M; Schütz C; Iffland D; Hampel G; Nawroth T; Langguth P
Radiat Oncol; 2015 Feb; 10():52. PubMed ID: 25889824
[TBL] [Abstract][Full Text] [Related]
9. MR characterization of mild hyperthermia-induced gadodiamide release from thermosensitive liposomes in solid tumors.
Peller M; Schwerdt A; Hossann M; Reinl HM; Wang T; Sourbron S; Ogris M; Lindner LH
Invest Radiol; 2008 Dec; 43(12):877-92. PubMed ID: 19002060
[TBL] [Abstract][Full Text] [Related]
10. Visualization of tumor angiogenesis using MR imaging contrast agent Gd-DTPA-anti-VEGF receptor 2 antibody conjugate in a mouse tumor model.
Jun HY; Yin HH; Kim SH; Park SH; Kim HS; Yoon KH
Korean J Radiol; 2010; 11(4):449-56. PubMed ID: 20592929
[TBL] [Abstract][Full Text] [Related]
11. MRI contrast agent for targeting glioma: interleukin-13 labeled liposome encapsulating gadolinium-DTPA.
Liu X; Madhankumar AB; Miller PA; Duck KA; Hafenstein S; Rizk E; Slagle-Webb B; Sheehan JM; Connor JR; Yang QX
Neuro Oncol; 2016 May; 18(5):691-9. PubMed ID: 26519740
[TBL] [Abstract][Full Text] [Related]
12. Hepatic metastases: liposomal Gd-DTPA-enhanced MR imaging.
Unger EC; Winokur T; MacDougall P; Rosenblum J; Clair M; Gatenby R; Tilcock C
Radiology; 1989 Apr; 171(1):81-5. PubMed ID: 2928550
[TBL] [Abstract][Full Text] [Related]
13. Targeted magnetic resonance imaging with intraperitoneal and intravenous streptavidin (SA)-DTPA-Gd: a comparative study in tumor-bearing nude mice.
Ye J; Xu YK; Liu X; Lü GS
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Feb; 26(2):139-43. PubMed ID: 16503514
[TBL] [Abstract][Full Text] [Related]
14. Dyke Award Paper. Kinetics of pathologic blood-brain-barrier permeability in an astrocytic glioma using contrast-enhanced MR.
Schmiedl UP; Kenney J; Maravilla KR
AJNR Am J Neuroradiol; 1992; 13(1):5-14. PubMed ID: 1595491
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics and imaging properties of Gd-EOB-DTPA in patients with hepatic and renal impairment.
Gschwend S; Ebert W; Schultze-Mosgau M; Breuer J
Invest Radiol; 2011 Sep; 46(9):556-66. PubMed ID: 21623212
[TBL] [Abstract][Full Text] [Related]
16. Gadolinium-chitosan nanoparticles as a novel contrast agent for potential use in clinical bowel-targeted MRI: a feasibility study in healthy rats.
Cheng JJ; Zhu J; Liu XS; He DN; Xu JR; Wu LM; Zhou J; Feng Q
Acta Radiol; 2012 Oct; 53(8):900-7. PubMed ID: 22919051
[TBL] [Abstract][Full Text] [Related]
17. Integrin αvβ3-targeted dynamic contrast-enhanced magnetic resonance imaging using a gadolinium-loaded polyethylene gycol-dendrimer-cyclic RGD conjugate to evaluate tumor angiogenesis and to assess early antiangiogenic treatment response in a mouse xenograft tumor model.
Chen WT; Shih TT; Chen RC; Tu SY; Hsieh WY; Yang PC
Mol Imaging; 2012; 11(4):286-300. PubMed ID: 22954145
[TBL] [Abstract][Full Text] [Related]
18. Targeted tumor MRI with gadobutrol-loaded anti-HER2 immunoliposomes.
Chen W; Liu B; Chen J; Liu G; Liu X
Acta Radiol; 2017 May; 58(5):573-580. PubMed ID: 27565629
[TBL] [Abstract][Full Text] [Related]
19. Gadolinium-conjugated PLA-PEG nanoparticles as liver targeted molecular MRI contrast agent.
Chen Z; Yu D; Liu C; Yang X; Zhang N; Ma C; Song J; Lu Z
J Drug Target; 2011 Sep; 19(8):657-65. PubMed ID: 21091273
[TBL] [Abstract][Full Text] [Related]
20. The efficacy of gadobenate dimeglumine (Gd-BOPTA) at 3 Tesla in brain magnetic resonance imaging: comparison to 1.5 Tesla and a standard gadolinium chelate using a rat brain tumor model.
Runge VM; Biswas J; Wintersperger BJ; Baumann SS; Jackson CB; Herborn CU; Patel T
Invest Radiol; 2006 Mar; 41(3):244-8. PubMed ID: 16481906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
